{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fevipiprant", "query": { "intervention": "Fevipiprant" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fevipiprant&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T20:41:54.451Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01253603", "title": "Efficacy, Safety, and Pharmacokinetics of QAW039", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "QAW039 capsules once daily for 28 days", "type": "DRUG" }, { "name": "Placebo to QAW039 capsules once daily for 28 days", "type": "DRUG" }, { "name": "Fluticasone propionate inhaler twice daily for 28 days", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 170, "start_date": "2010-11", "completion_date": "2011-09", "has_results": false, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 18, "location_summary": "Encinitas, California • Huntington Beach, California • Los Angeles, California + 13 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01253603" }, { "nct_id": "NCT03629249", "title": "Systemic Corticosteroids Avoidance Study in Severe Asthma Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo once daily", "type": "DRUG" }, { "name": "QAW039 150 mg once daily", "type": "DRUG" }, { "name": "QAW039 450 mg once daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 604, "start_date": "2018-12-13", "completion_date": "2020-02-06", "has_results": true, "last_update_posted_date": "2021-10-11", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 9, "location_summary": "Newport Beach, California • Westminster, California • Winter Park, Florida + 6 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Westminster", "state": "California" }, { "city": "Winter Park", "state": "Florida" }, { "city": "Bangor", "state": "Maine" }, { "city": "Waldorf", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03629249" }, { "nct_id": "NCT03650400", "title": "Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fevipiprant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 11, "start_date": "2019-05-01", "completion_date": "2020-01-22", "has_results": true, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 6, "location_summary": "Minneapolis, Minnesota • Columbia, Missouri • Tulsa, Oklahoma + 3 more", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Columbia", "state": "Missouri" }, { "city": "Tulsa", "state": "Oklahoma" }, { "city": "Boerne", "state": "Texas" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03650400" }, { "nct_id": "NCT03087942", "title": "Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Renal Insufficiency" ], "interventions": [ { "name": "QAW039", "type": "DRUG" }, { "name": "QAW39A", "type": "DRUG" }, { "name": "QAW39A2107", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 45, "start_date": "2017-07-05", "completion_date": "2018-08-07", "has_results": false, "last_update_posted_date": "2020-12-11", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03087942" }, { "nct_id": "NCT01437735", "title": "Dose Finding Study for QAW039 in Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QAW039", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 1043, "start_date": "2011-08", "completion_date": "2013-11", "has_results": false, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 38, "location_summary": "Scottsdale, Arizona • Encinitas, California • Huntington Beach, California + 33 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01437735" }, { "nct_id": "NCT02555683", "title": "Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QAW039", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 894, "start_date": "2015-12-11", "completion_date": "2019-11-04", "has_results": true, "last_update_posted_date": "2020-05-18", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Litchfield Park, Arizona + 49 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02555683" }, { "nct_id": "NCT03226392", "title": "Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QAW039", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 704, "start_date": "2017-10-31", "completion_date": "2019-08-01", "has_results": true, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 45, "location_summary": "Andalusia, Alabama • Birmingham, Alabama • Tucson, Arizona + 40 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03226392" }, { "nct_id": "NCT03052517", "title": "Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QAW039 150 mg", "type": "DRUG" }, { "name": "QAW039 450 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 2538, "start_date": "2017-03-21", "completion_date": "2020-03-16", "has_results": true, "last_update_posted_date": "2020-10-12", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 46, "location_summary": "Birmingham, Alabama • Encinitas, California • Newport Beach, California + 41 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Encinitas", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03052517" }, { "nct_id": "NCT03681093", "title": "Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nasal Polyps" ], "interventions": [ { "name": "Fevipiprant 150 mg", "type": "DRUG" }, { "name": "Fevipiprant 450 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 98, "start_date": "2019-03-26", "completion_date": "2020-06-10", "has_results": true, "last_update_posted_date": "2021-10-11", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 1, "location_summary": "Irvine, California", "locations": [ { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03681093" }, { "nct_id": "NCT01836471", "title": "A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QAW039", "type": "DRUG" }, { "name": "Placebo QAW039", "type": "DRUG" }, { "name": "Fluticasone 250 mcg", "type": "DRUG" }, { "name": "Fluticasone 100 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 345, "start_date": "2013-05", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2017-03-20", "last_synced_at": "2026-09-02T20:41:54.451Z", "location_count": 30, "location_summary": "Encinitas, California • Huntington Beach, California • Los Angeles, California + 24 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01836471" } ] }